The management of moderate to severe atopic dermatitis in adults with topical fluticasone propionate. The Netherlands Adult Atopic DermatitisStudy Group.
about
An Alternative Approach to Atopic Dermatitis: Part II—Summary of Cases and DiscussionPimecrolimus in atopic dermatitis: consensus on safety and the need to allow use in infantsRandomised controlled trial of short bursts of a potent topical corticosteroid versus prolonged use of a mild preparation for children with mild or moderate atopic eczemaEfficacy and tolerability of proactive treatment with topical corticosteroids and calcineurin inhibitors for atopic eczema: systematic review and meta-analysis of randomized controlled trials.New approaches to topical therapy.Therapeutic strategies: rotational therapy and combinations.Topical steroid addiction in atopic dermatitis.Treatment principles of atopic dermatitis.Expert consensus: time for a change in the way we advise our patients to use topical corticosteroids.Twice weekly fluticasone propionate added to emollient maintenance treatment to reduce risk of relapse in atopic dermatitis: randomised, double blind, parallel group studyAdverse effects of topical corticosteroids in paediatric eczema: Australasian consensus statement.Guidelines of care for the management of atopic dermatitis: Section 4. Prevention of disease flares and use of adjunctive therapies and approachesSafety and efficacy of fluticasone propionate in the topical treatment of skin diseases.Platycodon grandiflorus alleviates DNCB-induced atopy-like dermatitis in NC/Nga mice.Pediatric atopic dermatitis: should we treat it differently?Atopic dermatitis prevention.Review of pimecrolimus cream 1% in children for the treatment of mild to moderate atopic dermatitis.A systematic review of the safety of topical therapies for atopic dermatitis.A prospective study of atopic dermatitis managed without topical corticosteroids for a 6-month periodTopical fluticasone propionate: intervention and maintenance treatment options of atopic dermatitis based on a high therapeutic index.Long term treatment concepts and proactive therapy for atopic eczema.The care triangle: determining the gaps in the management of atopic dermatitis.Review of Atopic Dermatitis and Topical Therapies.Efficacy of topical azathioprine and betamethasone versus betamethasone-only emollient cream in 2-18 years old patients with moderate-to-severe atopic dermatitis: A randomized controlled trial.Methylprednisolone aceponate for atopic dermatitis.Difficult to control atopic dermatitisTopical corticosteroids in atopic dermatitis.Consensus guidelines for the management of atopic dermatitis: an Asia-Pacific perspective.Intermittent dosing of fluticasone propionate cream for reducing the risk of relapse in atopic dermatitis patients.Modulation of collagen synthesis and mRNA by continuous and intermittent use of topical hydrocortisone in human skin.Acute and maintenance treatment of atopic dermatitis in children - two comparative studies with fluticasone propionate (0.05%) cream.Topical corticosteroid phobia in patients with atopic eczema.Atopic eczema. What has caused the epidemic in industrialised countries and can early intervention modify the natural history of atopic eczema?[Maintenance treatment and early intervention--the new paradigm in the management of atopic eczema].Reduction of relapses of atopic dermatitis with methylprednisolone aceponate cream twice weekly in addition to maintenance treatment with emollient: a multicentre, randomized, double-blind, controlled study.A safety review of the medications used to treat atopic dermatitis.Treatment of Atopic Dermatitis From the Perspective of Traditional Persian Medicine: Presentation of a Novel Therapeutic Approach.Low basal serum cortisol in patients with severe atopic dermatitis: potent topical corticosteroids wrongfully accused.Guidelines for the management of atopic dermatitis (eczema) for pharmacists.Topical corticosteroid phobia in atopic dermatitis: a study of its nature, origins and frequency.
P2860
Q24806074-DDB4429A-38DD-409C-991A-88A4BE49A7D2Q28086973-DA0C6173-789D-4296-9EBC-BC28A9920D9FQ33559959-190FBB62-0C09-49CE-85C7-27AA762E7B10Q33684930-A282F7B8-0CDF-4CB5-9652-A03EEC50DEC5Q34106948-473F5A8E-B207-4052-A3CC-E66D99086B1FQ34291398-60A1E1EC-EF79-4568-AC49-F22A3BCF9895Q34394204-AEF91188-71AD-4EF0-862E-1719588E0FE2Q34600248-687274AB-E03D-4371-AF94-8B495AB102E1Q34753936-65682A8D-7262-41A7-8B3D-93A48BF569CEQ35107655-06B25005-4425-4175-ADA6-70C669A77386Q35573947-FE55607F-5DA5-4B4F-B4E6-9F0151F35F7EQ35603170-03C6EF00-A912-45FE-8B5C-E5C21B9A1206Q35988645-8950A0F5-F23B-402A-9FA9-D5FB369C9DB4Q36313468-7385704C-4183-484A-BBCD-97BC13C06930Q36466785-5A1F2998-5179-420A-AE65-18C6626DDE6AQ36466794-26907BE1-A4AA-4976-9F76-C35FFEA3E4C1Q36681795-8B1E103E-0F77-4E62-97B6-6425E5074C36Q36708358-6ECCDD5C-AAB0-4E49-BEEC-6FD9B2EE8D50Q37078489-EF55B409-6DC0-4A32-A11C-94B5EA3712F5Q37942962-D50E48F6-3119-4AC2-9FB7-2EC797425B44Q38033549-79274B7E-E40B-4EF0-83D4-0466FF96CEB4Q38118407-A757D3B9-9312-4E2E-9D36-F86C5C4A3454Q38744304-36875C84-442A-41EE-93A8-1AFD9ADA5913Q38936835-1A6584A8-596C-45FE-89C7-3AEDFA2FAC9EQ39160898-30CACFB6-E39E-4365-9A14-CE8A5BAF595FQ40473325-B3314E0A-A624-414E-957C-B9AA73077D9AQ43056856-FC5C5B65-C539-4661-AF4F-E6516DF326FBQ43609061-6B4B2243-5A80-4515-94E9-A336F9151C43Q44122718-9185AEBF-E124-4B8C-B211-CF44E3299C67Q44282556-6E6A015E-4079-45CE-8280-DA8D431859B8Q44604970-78A28424-08D9-4A15-B51A-DDA037E34035Q44730910-1426FA91-42A9-4F21-856B-C269B6A27186Q46436445-45717A73-E998-4E84-8C02-0D6B1700B30DQ46556720-8501CAD6-FE28-49E1-B3FD-A7818A8AADBDQ46745741-6B2A5463-48E3-40EC-94D3-D973EFE23D25Q47383323-EEC5F783-0ACD-4090-8520-DE027E1AB921Q47388285-CE973338-4324-4EBF-AA57-DC55A134BA92Q48273852-A8731886-E363-48A2-AF82-05AD9AF90293Q50144719-7410EAAA-EEF0-424F-AED7-62E36A90A60BQ50624212-C31B354F-26DF-4CC2-9EFA-FC67991526EA
P2860
The management of moderate to severe atopic dermatitis in adults with topical fluticasone propionate. The Netherlands Adult Atopic DermatitisStudy Group.
description
1999 nî lūn-bûn
@nan
1999 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հունիսին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
The management of moderate to ...... Atopic DermatitisStudy Group.
@ast
The management of moderate to ...... Atopic DermatitisStudy Group.
@en
type
label
The management of moderate to ...... Atopic DermatitisStudy Group.
@ast
The management of moderate to ...... Atopic DermatitisStudy Group.
@en
prefLabel
The management of moderate to ...... Atopic DermatitisStudy Group.
@ast
The management of moderate to ...... Atopic DermatitisStudy Group.
@en
P2093
P2860
P1476
The management of moderate to ...... Atopic DermatitisStudy Group.
@en
P2093
Coenraads PJ
Glazenburg EJ
Van Der Meer JB
P2860
P304
P356
10.1046/J.1365-2133.1999.02893.X
P407
P577
1999-06-01T00:00:00Z